Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.04 USD | +5.70% | -1.45% | -38.74% |
Financials (USD)
Sales 2024 * | 262M | Sales 2025 * | 357M | Capitalization | 232M |
---|---|---|---|---|---|
Net income 2024 * | -69M | Net income 2025 * | -20M | EV / Sales 2024 * | 1.91 x |
Net Debt 2024 * | 268M | Net Debt 2025 * | 286M | EV / Sales 2025 * | 1.45 x |
P/E ratio 2024 * |
-3.71
x | P/E ratio 2025 * |
-18.9
x | Employees | 306 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.92% |
Latest transcript on Coherus BioSciences, Inc.
1 day | +5.70% | ||
1 week | -1.45% | ||
Current month | -14.64% | ||
1 month | -11.30% | ||
3 months | -12.82% | ||
6 months | -25.55% | ||
Current year | -38.74% |
Managers | Title | Age | Since |
---|---|---|---|
Denny Lanfear
CEO | Chief Executive Officer | 68 | 10-08-31 |
Bryan Mcmichael
DFI | Director of Finance/CFO | 46 | 21-02-28 |
Chief Tech/Sci/R&D Officer | - | 21-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Stolper
BRD | Director/Board Member | 52 | 21-01-04 |
Mats Wahlström
BRD | Director/Board Member | 70 | 11-12-31 |
Ali Satvat
BRD | Director/Board Member | 46 | 14-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 2.04 | +5.70% | 907,173 |
24-04-25 | 1.93 | -4.46% | 2,220,138 |
24-04-24 | 2.02 | -7.34% | 879,713 |
24-04-23 | 2.18 | 0.00% | 811,796 |
24-04-22 | 2.18 | +5.31% | 1,499,626 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.74% | 219M | |
-2.31% | 103B | |
+0.56% | 95.71B | |
+1.69% | 22.02B | |
-17.37% | 20.9B | |
-9.30% | 17.85B | |
-41.01% | 16.21B | |
-14.85% | 15.52B | |
+3.21% | 13.86B | |
+33.54% | 12.04B |
- Stock Market
- Equities
- CHRS Stock